Oliguria causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→Causes) |
||
(16 intermediate revisions by 6 users not shown) | |||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Oliguria is the low output of urine below 300-500ml/day. The decreased output of urine may be causes by [[dehydration]], [[renal failure]], [[hypovolemic shock]], [[hyperosmolar nonketotic coma]], [[urinary retention]], [[DKA]], [[preeclampsia]], and [[urinary tract infections]] among other conditions. | Oliguria is the low output of urine below 300-500ml/day. The decreased output of urine may be causes by [[dehydration]], [[renal failure]], [[hypovolemic shock]], [[hyperosmolar nonketotic coma]], [[urinary retention]], [[DKA]], [[preeclampsia]], and [[urinary tract infections]] among other conditions. | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | |||
*[[Aneurysm|Aneurysmal rupture]] | *[[Aneurysm|Aneurysmal rupture]] | ||
*[[Accelerated hypertension]] | *[[Accelerated hypertension]] | ||
Line 56: | Line 57: | ||
*[[Sepsis]] | *[[Sepsis]] | ||
*[[SIADH]] | *[[SIADH]] | ||
*[[Third spacing of fluids| | *[[Third spacing of fluids|Third space losses]] | ||
*Urethral trauma | *[[urethral syndrome|Urethral trauma]] | ||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
Line 78: | Line 79: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[ACE inhibitors]], [[amatoxins]], [[aminoglycosides]], [[amphotericin B]], [[analgesic nephropathy]], [[anthracyclines]], [[arsenic trioxide]], [[bacitracin]], [[bendamustine]], [[bleomycin]], [[capecitabine]], [[capreomycin]], [[carbon tetrachloride]], [[carboplatin]], [[carmustine]], [[cidofovir]], [[cisplatin]], [[cyclophosphamide]], [[cyclosporine]], [[cytarabine]], [[deferasirox]], [[etoposide]], [[exenatide]], [[fluconazole]], [[fludarabine]], [[cladribine]], [[gallium]], [[gemcitabine]], [[gyromitrin]], [[Hydroxyethyl starch|hetastarch]], [[hydroxyurea]], [[ifosfamide]], [[Immune Globulin Intravenous Injection|immune globulin intravenous injection]], [[irinotecan]], [[lenalidomide]], [[lomustine]], [[hyperpyrexia|malignant hyperpyrexia following anesthesia]], [[mannitol]], [[melphalan]], [[methotrexate]], [[micafungin]], [[mithramycin]], [[nitrosourea compounds]], [[NSAIDs ]], [[orellanine]], [[oxaliplatin]], [[para-amino salicylic acid]], [[pemetrexed]], [[pentamidine]], [[pentostatin]], [[polymyxin B]], [[rifampicin]], [[sulfinpyrazone]], [[sulphonamide|sulphonamide crystalluria Cacluli]], [[Cannabinoids|synthetic cannabinoids]], [[tacrolimus]], [[taxanes]], [[telavancin]], [[temozolomide]], [[tenofovir]], [[topotecan]], [[valacyclovir]], [[vancomycin]], [[vinca alkaloids]] | |bgcolor="Beige"| [[ACE inhibitors]], [[Aldesleukin]], [[amatoxins]], [[aminoglycosides]], [[amphotericin B]], [[analgesic nephropathy]], [[anthracyclines]], [[arsenic trioxide]], [[bacitracin]], [[bendamustine]], [[bleomycin]], [[capecitabine]], [[capreomycin]], [[carbon tetrachloride]], [[carboplatin]], [[carmustine]], [[cidofovir]], [[cisplatin]], [[cyclophosphamide]], [[cyclosporine]], [[cytarabine]], [[deferasirox]], [[etoposide]], [[exenatide]], [[fluconazole]], [[fludarabine]], [[cladribine]], [[gallium]], [[gemcitabine]], [[gyromitrin]], [[Hydroxyethyl starch|hetastarch]], [[hydroxyurea]], [[ifosfamide]], [[Immune Globulin Intravenous Injection|immune globulin intravenous injection]], [[irinotecan]], [[lenalidomide]], [[Lincomycin Hydrochloride]], [[lomustine]], [[hyperpyrexia|malignant hyperpyrexia following anesthesia]], [[mannitol]], [[melphalan]], [[methotrexate]], [[micafungin]], [[mithramycin]], [[Nabilone]], [[nitrosourea compounds]], [[NSAIDs ]], [[orellanine]], [[oxaliplatin]], [[para-amino salicylic acid]], [[pemetrexed]], [[pentamidine]], [[pentostatin]], [[pramipexole]], [[polymyxin B]], [[rifampicin]], [[sertraline]], [[Streptozocin]], [[Sulfasalazine]], [[sulfinpyrazone]], [[sulphonamide|sulphonamide crystalluria Cacluli]], [[Cannabinoids|synthetic cannabinoids]], [[tacrolimus]], [[taxanes]], [[telavancin]], [[temozolomide]], [[tenofovir]], [[topotecan]], [[valacyclovir]], [[vancomycin]], [[vinca alkaloids]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 110: | Line 111: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| [[Diphtheria]] | |bgcolor="Beige"| [[Diphtheria]], [[endometriosis]], [[septic shock|endotoxic shock]], [[enteritis]], [[epidemic dropsy]], [[hantavirus]], [[ehrlichiosis|human monocytotropic ehrlichiosis]], [[lassa fever]], [[leptospirosis]], [[malaria|malignant malaria]], [[mycobacterium tuberculosis]], [[gonorrhoea|neisseria gonorrhoea]], [[post-streptococcal glomerulonephritis]], [[schistosoma haematobium]], [[septic shock]], [[systemic inflammatory response syndrome]], [[toxic shock syndrome]] | ||
| | | | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 126: | Line 127: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| [[Cervical cancer]], [[endometriosis]], hydrometrocolpos, [[hyperemesis gravidarum]], [[ovarian hyperstimulation syndrome]], [[perinatal asphyxia]], [[postpartum bleeding]], [[pre-eclampsia]], [[ | |bgcolor="Beige"| [[Cervical cancer]], [[endometriosis]], [[vulvovaginal health|hydrometrocolpos]], [[hyperemesis gravidarum]], [[ovarian hyperstimulation syndrome]], [[perinatal asphyxia]], [[postpartum bleeding]], [[pre-eclampsia]], [[pregnancy toxemia]], [[puerperal fever|puerperal shock]], [[twin-to-twin transfusion syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 158: | Line 159: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Sexual''' | | '''Sexual''' | ||
|bgcolor="Beige"| [[Benign prostatic hyperplasia]], hydrometrocolpos | |bgcolor="Beige"| [[Benign prostatic hyperplasia]], [[Vulvovaginal health|hydrometrocolpos]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 166: | Line 167: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Urologic''' | | '''Urologic''' | ||
|bgcolor="Beige"| [[Benign prostatic hyperplasia]], [[bladder cancer]], [[obstructive uropathy|bladder outlet obstruction]], [[hydronephrosis]], [[kidney stone]], [[nephrotic syndrome]], [[obstructive uropathy|obstruction of the urinary tract]], [[pelvic masses|pelvic tumor]], [[prostate cancer]], [[schistosoma haematobium]], [[sulphonamide|sulphonamide crystalluria]], [[ureterocele]], [[urethral catheterization]], [[urethral stricture]], urethral trauma | |bgcolor="Beige"| [[Benign prostatic hyperplasia]], [[bladder cancer]], [[obstructive uropathy|bladder outlet obstruction]], [[hydronephrosis]], [[kidney stone]], [[nephrotic syndrome]], [[obstructive uropathy|obstruction of the urinary tract]], [[pelvic masses|pelvic tumor]], [[prostate cancer]], [[schistosoma haematobium]], [[sulphonamide|sulphonamide crystalluria]], [[ureterocele]], [[urethral catheterization]], [[urethral stricture]], [[urethral syndrome|urethral trauma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| [[running|Marathon running]], post-resustication syndrome, [[puerperal fever|puerperal shock]], [[radiotherapy]], [[surgery|surgery complication]] | |bgcolor="Beige"| [[running|Marathon running]], [[emergency medicine|post-resustication syndrome]], [[puerperal fever|puerperal shock]], [[radiotherapy]], [[surgery|surgery complication]] | ||
|- | |- | ||
|} | |} | ||
Line 177: | Line 178: | ||
{{col-begin|width=85%}} | {{col-begin|width=85%}} | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Accelerated hypertension]] | *[[Accelerated hypertension]] | ||
*[[ACE inhibitors]] | *[[ACE inhibitors]] | ||
Line 197: | Line 197: | ||
*[[Analgesic nephropathy]] | *[[Analgesic nephropathy]] | ||
*[[Anaphylaxis|Anaphylaxis and anaphylactoid reactions]] | *[[Anaphylaxis|Anaphylaxis and anaphylactoid reactions]] | ||
*[[Aneurysm|Aneurysmal rupture]] | |||
*[[Anthracyclines]] | *[[Anthracyclines]] | ||
*[[Antiphospholipid Antibody Syndrome]] | *[[Antiphospholipid Antibody Syndrome]] | ||
Line 246: | Line 247: | ||
*[[Disseminated intravascular coagulation]] | *[[Disseminated intravascular coagulation]] | ||
*[[Diuretics]] | *[[Diuretics]] | ||
*[[Drug overdose]] | *[[Drug overdose]] | ||
*[[Eclampsia]] | *[[Eclampsia]] | ||
Line 278: | Line 278: | ||
*[[Hydroxyethyl starch|Hetastarch]] | *[[Hydroxyethyl starch|Hetastarch]] | ||
*[[ehrlichiosis|Human monocytotropic ehrlichiosis]] | *[[ehrlichiosis|Human monocytotropic ehrlichiosis]] | ||
*Hydrometrocolpos | *[[vulvovaginal health|Hydrometrocolpos]] | ||
*[[Hydronephrosis]] | *[[Hydronephrosis]] | ||
*[[Hydroxyurea]] | *[[Hydroxyurea]] | ||
Line 318: | Line 318: | ||
*[[Myoglobinuria]] | *[[Myoglobinuria]] | ||
*[[Myxedema coma]] | *[[Myxedema coma]] | ||
*[[Nabilone]] | |||
*[[gonorrhoea|Neisseria gonorrhoea]] | *[[gonorrhoea|Neisseria gonorrhoea]] | ||
*[[Nephritic syndrome]] | *[[Nephritic syndrome]] | ||
Line 343: | Line 344: | ||
*[[Porphyria]] | *[[Porphyria]] | ||
*[[Postpartum bleeding]] | *[[Postpartum bleeding]] | ||
*Post-resuscitation syndrome | *[[emergency medicine|Post-resuscitation syndrome]] | ||
*[[Post-streptococcal glomerulonephritis]] | *[[Post-streptococcal glomerulonephritis]] | ||
* [[Pregnancy toxemia]] | * [[Pregnancy toxemia]] | ||
Line 375: | Line 376: | ||
*[[Snake bite (Viperidae)]] | *[[Snake bite (Viperidae)]] | ||
*[[Spinal cord compression]] | *[[Spinal cord compression]] | ||
*[[Streptozocin]] | |||
*[[Myocardial stunning]] | *[[Myocardial stunning]] | ||
*[[Sulfinpyrazone]] | *[[Sulfinpyrazone]] | ||
Line 403: | Line 405: | ||
*[[Urethral catheterization]] | *[[Urethral catheterization]] | ||
*[[Urethral stricture]] | *[[Urethral stricture]] | ||
*Urethral trauma | *[[urethral syndrome|Urethral trauma]] | ||
*[[Valacyclovir]] | *[[Valacyclovir]] | ||
*[[Vancomycin]] | *[[Vancomycin]] | ||
Line 413: | Line 415: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Crowdiagnosis]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Nephrology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Latest revision as of 15:46, 12 February 2015
Oliguria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oliguria causes On the Web |
American Roentgen Ray Society Images of Oliguria causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mugilan Poongkunran M.B.B.S [2]
Overview
Oliguria is the low output of urine below 300-500ml/day. The decreased output of urine may be causes by dehydration, renal failure, hypovolemic shock, hyperosmolar nonketotic coma, urinary retention, DKA, preeclampsia, and urinary tract infections among other conditions.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Aneurysmal rupture
- Accelerated hypertension
- Acute blood loss
- Acute cortical necrosis
- Acute systemic inflammation following acute myocardial infarction
- Acute tubular necrosis
- Anaphylaxis and anaphylactoid reactions
- Bowel strangulation
- Burns
- Carbon monoxide poisoning
- Cardiogenic shock
- Crush syndrome
- Disseminated intravascular coagulation
- Drug overdose
- Eclampsia
- Endotoxic shock
- Heat stroke
- Hyperosmolar non-ketotic diabetic coma
- Massive pulmonary embolism
- Mismatched blood transfusion
- Neurogenic shock after central nervous system or spinal cord injury
- Pericardial tamponade
- Severe constrictive pericarditis
Common Causes
- ACE inhibitors
- Acute renal failure
- Acute tubular necrosis
- Aminoglycosides
- Analgesic nephropathy
- Capillary leak
- Dehydration
- Diarrhoea
- Diuretics
- Interstitial nephritis
- Massive bleeding
- Nephritic syndrome
- Nephrolithiasis
- Nephrotic syndrome
- Neurogenic bladder
- NSAIDs
- Posterior urethral valves
- Postpartum bleeding
- Prostate enlargement
- Renal artery thrombosis
- Sepsis
- SIADH
- Third space losses
- Urethral trauma